Stelliam Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-130,500
Closed -$27.1M 22
2018
Q3
$27.1M Sell
130,500
-32,500
-20% -$6.4M 1.45% 24
2018
Q2
$30.1M Sell
163,000
-17,000
-9% -$3.01M 1.39% 29
2018
Q1
$30.7M Sell
180,000
-54,000
-23% -$9.91M 1.28% 32
2017
Q4
$40.7M Buy
234,000
+26,500
+13% +$4.69M 1.68% 29
2017
Q3
$38.7M Buy
207,500
+12,500
+6% +$2.21M 1.18% 34
2017
Q2
$33.6M Sell
195,000
-177,500
-48% -$28.9M 1.08% 39
2017
Q1
$61.1M Sell
372,500
-162,500
-30% -$27M 2.35% 15
2016
Q4
$78.2M Buy
535,000
+157,500
+42% +$23.7M 2.6% 15
2016
Q3
$63M Sell
377,500
-180,000
-32% -$30.4M 2.11% 19
2016
Q2
$84.8M Sell
557,500
-66,000
-11% -$10.3M 2.93% 10
2016
Q1
$93.5M Buy
623,500
+136,000
+28% +$20.2M 2.89% 14
2015
Q4
$79.1M Sell
487,500
-7,200
-1% -$1.13M 2.36% 17
2015
Q3
$68.4M Sell
494,700
-35,300
-7% -$5.56M 1.7% 24
2015
Q2
$81.4M Buy
530,000
+22,500
+4% +$3.6M 1.72% 19
2015
Q1
$81.1M Buy
507,500
+85,000
+20% +$13.4M 1.83% 20
2014
Q4
$67.3M Sell
422,500
-27,500
-6% -$4.29M 1.55% 23
2014
Q3
$63.2M Sell
450,000
-112,500
-20% -$14.7M 1.67% 25
2014
Q2
$66.6M Buy
562,500
+155,000
+38% +$17.9M 1.78% 22
2014
Q1
$50.3M Buy
407,500
+7,500
+2% +$910K 1.66% 27
2013
Q4
$45.7M Buy
+400,000
New +$45.5M 1.86% 23

Other funds holding AMGN

Stelliam Investment Management's AMGN Position: Q4 2018 in Review

Stelliam Investment Management sold out of Amgen (AMGN) in Q4 2018, closing a stake of 130,500 shares — an estimated $27.1M sold.

Stelliam Investment Management first reported a position in AMGN in Q4 2013 and held it in 20 quarters. The position peaked at $93.5M in Q1 2016. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Stelliam Investment Management reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • Stelliam Investment Management sold 130,500 Amgen shares in Q4 2018, an estimated $27.1M.
  • Stelliam Investment Management first reported a position in Amgen in Q4 2013 and held it in 20 quarters.
  • Stelliam Investment Management's Amgen position peaked at $93.5M in Q1 2016.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Stelliam Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.